How do I get free insulin if I can't afford it?

The fastest paths to free or very low-cost insulin are the manufacturer patient assistance programs (PAPs). Eli Lilly's Insulin Value Program caps copays at $35 per month even without insurance, and their Lilly Cares Foundation PAP offers free insulin to income-qualifying patients. Novo Nordisk's Patient Assistance Program (PAP) provides free Novo insulins to uninsured or underinsured patients below income thresholds (roughly 400% of the federal poverty level). Sanofi's Insulins Valyou Savings Program offers similar savings. Apply directly through each manufacturer's website or by calling their patient support line. Your prescribing physician's office can often assist with paperwork. Resources like NeedyMeds.org and RxAssist.org catalog hundreds of PAPs in one place.

What insulin assistance programs are available for diabetics?

There are several layers: (1) Manufacturer PAPs — Eli Lilly, Novo Nordisk, and Sanofi each run programs for income-qualifying uninsured or underinsured patients. (2) Medicare Part D insulin cap — $35/month per covered insulin, effective 2023. (3) State caps — more than a dozen states have capped insulin costs at $25–$100/month for residents on state-regulated insurance plans. (4) GoodRx and NeedyMeds — price-comparison and coupon tools that can cut retail costs significantly. (5) 340B pharmacies and FQHCs — federally qualified health centers serve patients on a sliding-scale fee regardless of insurance status. (6) Medicare Extra Help (Low Income Subsidy) and Medicaid for those who qualify on income. Start with your prescriber, pharmacist, or a social worker at your clinic — they often know program details specific to your insulin brand.

How does the $35 insulin copay cap work?

The Inflation Reduction Act of 2022 capped out-of-pocket costs for insulin covered under Medicare Part D (prescription drug plans) at $35 per month per insulin product, effective January 1, 2023. The cap also applies to insulin dispensed through Medicare Part B (for insulin pumps). This applies regardless of which deductible phase you are in — you pay no more than $35 even before meeting your deductible. If you are on Medicare, check with your Part D plan or medicare.gov to confirm your covered insulin qualifies. The cap does not automatically apply to all private employer or marketplace plans — check with your insurer. Many states have separately enacted their own caps for state-regulated plans.

Where can I find low-cost or cheap insulin?

Several options: (1) GoodRx (goodrx.com) — enter your insulin name and zip code to see cash-pay prices at local pharmacies; GoodRx coupons are free to use. (2) Walmart ReliOn insulin — over-the-counter NPH and Regular human insulins (not analogs) available for roughly $25 per vial without a prescription; ask your prescriber if any of these formulations could work as a bridge option. (3) 340B-participating pharmacies — hospitals and health centers enrolled in the federal 340B Drug Pricing Program buy drugs at significantly reduced prices; if you receive care at a qualifying facility, you may access those prices. (4) NeedyMeds (needymeds.org) — free drug discount card and program database. Always tell your pharmacist and prescriber you are experiencing cost hardship — they often know local options that are not widely advertised.

What is the Lilly Insulin Value Program and how do I qualify?

Eli Lilly's Insulin Value Program caps out-of-pocket insulin costs at $35 per month for patients who have commercial (private) insurance as well as uninsured patients, regardless of income. The program covers all Lilly insulins (Humalog, Basaglar, Humulin, and others). You can get the savings card at the pharmacy counter or at insulinaffordability.com. For patients who have no insurance and are income-eligible, the separate Lilly Cares Foundation Patient Assistance Program can provide insulin at no cost. Income thresholds and program terms can change — check the Lilly Cares website or call 1-800-545-5979 for current eligibility details. This is not medical advice; confirm formulary and dose specifics with your prescriber.

How do I apply for the Novo Nordisk patient assistance program?

Novo Nordisk's Patient Assistance Program (PAP) provides free Novo Nordisk insulins (Tresiba, Levemir, Novolog, and others) to uninsured or underinsured patients who meet income guidelines — generally up to 400% of the federal poverty level. Applications are typically completed with your prescriber's participation. You can start at novonordisk-us.com or call 1-866-310-7549. Bring documentation of your income and insurance status. For patients with insurance but high out-of-pocket costs, Novo also offers separate savings cards — ask your pharmacist or check the website. Program terms and eligibility thresholds can change; verify details directly with Novo Nordisk.

How can I get help paying for Lantus?

Lantus is made by Sanofi. Sanofi's Insulins Valyou Savings Program has historically offered savings for people with or without insurance, and Sanofi's PAP (Patient Assistance Program) can provide Lantus at no cost to income-qualifying uninsured patients. Start at insulinsvalyou.com or call 1-888-847-4877. GoodRx can also show you the lowest cash-pay price available in your area. Ask your prescriber whether a biosimilar (such as Semglee, which is FDA-approved as interchangeable with Lantus) might lower your cost — biosimilars are often significantly less expensive. This page provides general information, not medical advice; work with your prescriber and pharmacist on any changes to your regimen.

Does putting insulin costs on a credit card or CareCredit affect my credit?

Yes, in multiple ways. Regular credit card balances that grow over time increase your credit utilization ratio, which can lower your credit score even if you pay on time. If you miss payments because monthly costs are unmanageable, late payments are reported to the credit bureaus and remain for seven years. Medical credit cards like CareCredit typically offer deferred-interest financing — if you do not pay the full balance by the promotional deadline, all the accrued interest can be charged at once at rates of 26%+. The better path is to cut the cost of the medication first (using the programs above), then address any existing balance through the strategies in this guide.

Insulin Assistance Programs and Help Paying for Prescription Debt (2026 Guide)

If you are rationing insulin, skipping test strips, or putting Humalog on a credit card just to survive the month, you are not alone — roughly one in four diabetics in the US has reported doing exactly that. The good news: several levers can dramatically cut what you pay for insulin and supplies before you need to touch a debt program. This guide puts those free and low-cost options first, then addresses the balances already on your card, with honest trade-offs attached.

Step 1: cut the cost of insulin and supplies — before financing them

Debt programs can help with balances you have already accumulated. But if the root cause — the monthly cost of insulin and diabetic supplies — keeps outpacing your income, adding more tools and more interest compounds the problem. The most important financial move a diabetic can make is to cut that recurring cost first. The programs below are real, federally and commercially funded, and used by millions of patients every year. Many people who qualify never apply because they do not know the options exist.

This guide provides general information, not medical advice. Any changes to your insulin type, dose, or brand must be made in coordination with your prescriber and pharmacist — do not make medication changes based on cost alone without medical guidance.

The $35/month insulin cap — Medicare and state plans

The Inflation Reduction Act of 2022 capped out-of-pocket costs for insulin covered under Medicare Part D at $35 per month per insulin product, effective January 1, 2023. The same cap applies to insulin dispensed through Medicare Part B for use in insulin pumps. Critically, the $35 cap applies even before you meet your deductible — you will not pay more than $35 per covered insulin in any phase of the benefit year.

If you are on Medicare, confirm with your Part D plan or at medicare.gov that your specific insulin product is on the plan's formulary. The cap applies to covered drugs — if your insulin is not on formulary, ask your prescriber about a covered alternative or request a formulary exception. You can also compare Part D plans during Open Enrollment (October 15–December 7 each year) to find one that covers your insulin at the $35 rate.

State insulin cost caps

Even if you are not on Medicare, your state may have acted separately. As of 2026, more than a dozen states — including California, Colorado, Illinois, Maine, Minnesota, New Mexico, New York, Oregon, Virginia, Washington, West Virginia, and others — have capped insulin costs for residents on state- regulated insurance plans, typically at $25–$100 per month. These caps apply to fully insured employer and individual market plans regulated by the state; self-insured employer plans (governed by federal ERISA law) are generally not covered by state caps. Check your state's department of insurance website or call the plan directly to confirm whether the cap applies to your coverage.

Manufacturer patient assistance programs (PAPs)

The three largest insulin manufacturers in the US — Eli Lilly, Novo Nordisk, and Sanofi — each run patient assistance programs that can provide insulin at sharply reduced cost or entirely free for income-qualifying patients. These programs are separate from, and in addition to, state or Medicare caps.

Eli Lilly: Insulin Value Program and Lilly Cares Foundation

Eli Lilly offers two layers of help. The Insulin Value Program caps out-of-pocket costs at $35 per month for commercially insured patients and for uninsured patients, regardless of income. It covers Humalog, Basaglar, Humulin, Lyumjev, and other Lilly insulins. You can get the savings card at a participating pharmacy counter or at insulinaffordability.com.

For uninsured or underinsured patients who also meet income guidelines, the separate Lilly Cares Foundation PAP can provide insulin at no cost. Your prescriber submits the enrollment form on your behalf. Call 1-800-545-5979 or visit lillycares.com for eligibility details, which can change; verify current thresholds directly.

Novo Nordisk: Patient Assistance Program and savings cards

Novo Nordisk's Patient Assistance Program (PAP) provides free Novo insulins — including Tresiba, Levemir, Novolog, and Fiasp — to uninsured or underinsured patients at or below approximately 400% of the federal poverty level. Applications require your prescriber's signature and documentation of income and insurance status. Start at novonordisk-us.com/patients/patient-assistance or call 1-866-310-7549.

If you have insurance but face high copays, Novo Nordisk also offers separate savings cards. Ask your pharmacist or check the website — the programs available vary by product and insurance type. Program terms can change; confirm eligibility details directly.

Sanofi: Insulins Valyou Savings Program and PAP

Sanofi's Insulins Valyou Savings Program has offered savings on Lantus, Toujeo, Admelog, and other Sanofi insulins for patients with or without insurance. Sanofi also maintains a PAP that can provide insulin free to income-qualifying uninsured patients. Start at insulinsvalyou.com or call 1-888-847-4877. Ask your prescriber whether a biosimilar such as Semglee (FDA-approved as interchangeable with Lantus) might reduce your cost further — biosimilars are frequently less expensive and may have their own savings programs.

Finding other PAPs: NeedyMeds and RxAssist

Patient assistance programs exist for many non-insulin diabetes medications, supplies, and CGM systems as well. Two free databases cover hundreds of programs:

NeedyMeds.org (needymeds.org) — searchable database of manufacturer PAPs, state programs, and disease-specific foundations. Also offers a free drug discount card accepted at most pharmacies.
RxAssist.org (rxassist.org) — similar database with program-by-program eligibility and application instructions.

Your prescriber's office or a social worker at your clinic will often have experience with these programs and can help with the paperwork — do not hesitate to ask.

GoodRx, NeedyMeds drug discount card, and 340B pharmacies

Even if you do not qualify for a PAP, cash prices for insulin vary widely between pharmacies — and discount tools can close much of that gap.

GoodRx

GoodRx.com lets you enter any drug name and your zip code to compare cash-pay prices at nearby pharmacies and get a free coupon. For many insulin products, GoodRx prices are significantly lower than a pharmacy's standard retail price. GoodRx coupons cannot typically be combined with insurance; use whichever is lower. GoodRx is free to use — you do not need to sign up to compare prices, though some features require a free account.

Walmart ReliOn human insulin

For patients whose prescriber confirms that a human insulin formulation (NPH or Regular) is medically appropriate as a bridge or permanent option, Walmart sells ReliOn-brand human insulins over the counter for approximately $25 per vial without a prescription in most states. Human insulins behave differently from analog insulins (like Humalog or Lantus) — they require a longer action window and different timing. Do not switch insulin types without discussing it with your prescriber first. This option is noted here because some patients on a tight budget have used it under physician guidance; it is not a universal substitute.

340B pharmacies

The federal 340B Drug Pricing Program requires pharmaceutical manufacturers to provide outpatient drugs to eligible health centers at significantly reduced prices. If you receive care at a qualifying hospital outpatient department, Federally Qualified Health Center (FQHC), or look-alike clinic, you may be able to access drugs at 340B prices through their pharmacy. Ask the pharmacy or billing staff whether the facility participates in 340B and whether you qualify — eligibility is tied to receiving care at the covered entity, not income alone.

Medicaid, Medicare Extra Help, and Medicare Savings Programs

Government coverage programs can eliminate or drastically reduce prescription costs — and many people who qualify do not realize it.

Medicaid

Medicaid provides low-cost or free health coverage, including prescription drug coverage, to adults below certain income levels. In states that have expanded Medicaid under the Affordable Care Act (most states), adults up to 138% of the federal poverty level typically qualify. Medicaid covers insulin and most diabetic supplies, often with a $0 or very low copay. Apply through your state's Medicaid office or at healthcare.gov. Even if you have been denied before, income thresholds change and it is worth re-applying if your financial situation has worsened.

Medicare Extra Help (Low Income Subsidy, LIS)

If you are on Medicare and your income is at or below 150% of the federal poverty level, the Medicare Extra Help program (also called the Low Income Subsidy, or LIS) can substantially reduce Part D premiums, deductibles, and copays — including the cost of insulin. Under Extra Help, insulin copays may be $0 or a few dollars per fill. Apply online through the SSA at ssa.gov/benefits/medicare/prescriptionhelp or call 1-800-772-1213.

Medicare Savings Programs

Medicare Savings Programs (MSPs) — Qualified Medicare Beneficiary (QMB), Specified Low-Income Medicare Beneficiary (SLMB), Qualifying Individual (QI), and Qualified Disabled and Working Individual (QDWI) — help pay Medicare premiums, deductibles, and cost-sharing. Qualifying for QMB or SLMB also automatically qualifies you for Extra Help. Apply through your state Medicaid office. Income and asset limits vary by program; benefits.gov can help you screen for eligibility.

ADAP and state pharmaceutical assistance programs

Some states maintain their own pharmaceutical assistance programs for residents with specific chronic conditions or income levels. Your state health department or a pharmacist at a community health center may know of programs specific to your state. The Patient Advocate Foundation (patientadvocate.org) also maintains a Co-Pay Relief program that provides grants for prescription copays for qualifying patients with specific diagnoses, including diabetes.

FQHC sliding-scale community health centers

Federally Qualified Health Centers (FQHCs) are federally funded clinics required to serve patients regardless of ability to pay, using a sliding-scale fee schedule tied to income. For uninsured or underinsured diabetics, FQHCs provide primary care, diabetes management, prescriptions through 340B pricing, and often diabetes education — all at a cost adjusted to what you can afford. Many also have on-site pharmacies. Find an FQHC near you at findahealthcenter.hrsa.gov. Transferring your diabetes care to an FQHC can reduce both your medical and prescription costs simultaneously if you are currently paying full out-of-pocket rates.

Hospital and pharmacy charity care (IRS 501(r))

If you have received hospital-based infusion, emergency treatment, or outpatient diabetes care that resulted in a medical bill, remember: most nonprofit hospitals are required by IRS Section 501(r) to maintain a written financial assistance policy (FAP) — often called charity care — and to offer it to patients who qualify based on income and financial hardship. Many hospitals use 200%–400% of the federal poverty level as their eligibility ceiling. The policy can reduce or fully eliminate a hospital bill, not just the prescription portion.

Ask the hospital's billing or patient financial services department specifically for the financial assistance policy or charity care application. The nonprofit Dollar For (dollarfor.org) provides free help applying for hospital financial assistance and can be especially useful if navigating the paperwork while managing a chronic illness feels overwhelming. For a full guide to disputing medical billing errors, requesting itemized statements, and negotiating hospital bills, see our medical debt relief guide.

The debt you already took on to pay for meds

If you have already put insulin and supplies on a credit card, a medical credit card (like CareCredit), or taken out a payday loan to afford a prescription fill, those balances are now unsecured consumer debt — and they need a strategy separate from cutting future costs.

Call your creditors' hardship lines first

Before missing a payment, call each issuer's hardship department. Ask specifically for financial hardship assistance. Many major issuers have programs that can temporarily reduce interest rates, waive minimum payments for a few months, or suspend late fees — options that are not widely advertised but are available if you ask. Even a brief reprieve can buy time while you work through the prescription-cost levers above.

Nonprofit credit counseling (NFCC)

A nonprofit credit counselor through NFCC.org can review your full financial picture — income, expenses, all debt balances — at no cost and help you build a realistic plan. If you can make some consistent monthly payment, a debt management plan (DMP) may fit: creditors often agree to reduce interest rates (sometimes to 6–10%), and you repay the full principal over three to five years at meaningfully lower total cost, with less credit damage than settlement. NFCC member agencies are nonprofit and charge modest fees (typically $25–$55 a month) or waive them based on hardship. This is often the right first call for leftover prescription-cost card debt.

When debt settlement may apply — with real trade-offs

If your unsecured credit card and medical-credit balances from prescription costs are genuinely more than you can repay — even with creditor hardship accommodations and a DMP — then debt settlement is worth understanding. A settlement program negotiates with creditors to accept a reduced lump-sum payoff on your enrolled unsecured accounts.

The trade-offs are real and must be understood before enrolling:

Credit score impact: Settlement programs typically require stopping payments while you build a settlement fund. Missed payments are reported to the credit bureaus and lower your score. Settled accounts are reported as settled for less than the full balance. The damage can be significant.
Taxable forgiven debt: When a creditor forgives $600 or more of principal, they are generally required to issue an IRS Form 1099-C. The IRS treats forgiven debt as taxable income in the year of settlement unless you qualify for the insolvency exclusion (IRS Form 982). Consult a tax professional before assuming the exclusion applies to you.
Not guaranteed: Creditors are not required to accept any settlement offer. Results vary by creditor, balance size, and account age. No legitimate settlement company can promise a specific outcome or savings amount — be wary of anyone who does.
Unsecured only: Settlement applies only to unsecured debt — credit cards, personal loans, and medical credit cards. It does not apply to secured debt (auto loans, mortgages) and should not be used for a medical bill still held by the original provider, which may be eligible for charity care or an interest-free payment plan instead.

The rough pre-qualification threshold for most settlement programs is $7,500 or more in unsecured debt and a genuine financial hardship — which chronic prescription debt can clearly represent. Our primary settlement partner is National Debt Relief, which offers a free, no-obligation estimate that does not affect your credit. Compare a DMP (full principal repayment, less credit damage) against settlement (reduced principal, more credit impact) based on your actual balance and realistic income picture. For the full settlement trade-off explainer, see our how debt settlement works guide.

How prescription debt affects your credit

The type of debt matters. A medical bill held by your provider or hospital behaves differently from prescription costs you charged to a credit card. Under credit-bureau rule changes that took effect in 2023–2024, medical collections under $500 were removed from consumer credit reports, and the timeline before medical debt in collections appears on a report was extended. Medical debt currently has weaker credit-score impact than revolving credit card debt for many people.

But prescription costs you put on a credit card or medical credit card are treated as credit card debt — not medical debt — by the credit bureaus. High utilization, missed payments, and delinquencies on those cards follow the standard credit-scoring rules with full impact. The implication: it is better to work with your prescriber and the programs above to cut costs at the source than to convert a potential charity-care-eligible medical bill into high-interest credit card debt. If you have already done so, the strategies above apply to those balances. See our full medical debt relief guide for disputing billing errors and negotiating with providers on bills held directly by the hospital.

Free resources — start here

Lilly Insulin Affordability (Lilly Insulin Value Program): insulinaffordability.com — $35/month cap for insured and uninsured patients; separate Lilly Cares PAP for income-qualifying patients.
Lilly Cares Foundation PAP: lillycares.com or 1-800-545-5979 — free Lilly insulin for income-qualifying uninsured/underinsured patients.
Novo Nordisk PAP: novonordisk-us.com or 1-866-310-7549 — free Novo insulins for income-qualifying patients.
Sanofi Insulins Valyou / PAP: insulinsvalyou.com or 1-888-847-4877 — savings and PAP for Lantus, Toujeo, and other Sanofi insulins.
NeedyMeds.org: needymeds.org — free database of manufacturer PAPs, state programs, and discount cards for all medications.
RxAssist.org: rxassist.org — companion PAP database with eligibility and application details.
GoodRx: goodrx.com — free price comparison and coupon tool for prescriptions at local pharmacies.
Find a Health Center (FQHC locator): findahealthcenter.hrsa.gov — HRSA locator for federally qualified health centers with sliding-scale fees.
Medicare Extra Help (LIS): ssa.gov/benefits/medicare/prescriptionhelp or 1-800-772-1213 — reduces Part D costs to near zero for income-qualifying Medicare enrollees.
Medicare.gov Plan Finder: medicare.gov/plan-compare — compare Part D plans to find the lowest out-of-pocket cost for your specific insulins.
Benefits.gov eligibility screener: benefits.gov — screens for Medicaid, SNAP, TANF, MSPs, and other federal assistance programs.
Dollar For (hospital charity care assistance): dollarfor.org — free nonprofit that helps patients apply for hospital financial assistance.
Patient Advocate Foundation (Co-Pay Relief): patientadvocate.org — prescription copay grants and case management at no cost; diabetes is a covered condition.
NFCC.org (nonprofit credit counseling): nfcc.org — free or low-cost debt counseling from nonprofit agencies; first call before any paid debt program.
CFPB (debt collector complaints): consumerfinance.gov/complaint — file complaints about abusive collectors and read plain-language guides on your rights.
ADA (American Diabetes Association) advocacy and resources: diabetes.org/advocacy — policy updates, state-by-state cap tracker, and financial resources for people with diabetes.